Brief: Astellas Pharma, Yaskawa Electric: Agree To Establish Joint Venture Focused On Cell Therapy Manufacturing
06/03/2025 04:06
March 6 (Reuters) - Astellas Pharma Inc 4503.T: ASTELLAS PHARMA, YASKAWA ELECTRIC: AGREE TO ESTABLISH JOINT VENTURE FOCUSED ON CELL THERAPY MANUFACTURING Source text: https://www.astellas.com/en/news/29761 Further company coverage: 4503.T (Reporting by Kantaro Komiya) ((Kantaro.Komiya@thomsonreuters.com;))
Recent news on Astellas Pharma
See all newsBrief: Immuneering To Collaborate With Astellas On Clinical Studies Of Investigational CLDN18.2 Programs In Combination With Atebimetinib For Pancreatic Cancer Patients
Health Rounds: New blood test finds early risk for ovarian cancer
Health Rounds: New blood test finds early risk for ovarian cancer
Refile: Astellas employee imprisoned in China to be released in December, Japanese media report
Table: Astellas Pharma -6-MTH group results (IFRS)